Document Type
Conference Proceeding - Restricted Access
Publication Date
3-9-2022
Publication Title
Journal of Parenteral and Enteral Nutrition ( JPEN )
Abstract
Background: Parenteral composite lipid emulsion has been shown to provide an anti‐inflammatory effect. Recent meta‐analysis demonstrated a reduced hospital and intensive care unit lengths of stay (LOS) and reduced rates of infections with composite lipid emulsion. The study site used parenteral soy‐based lipids in critically ill patients prior to 2017 and composite lipids were used based on criteria‐based. In 2020, composite lipids were approved for use in all critically ill patients at the study site. This study evaluated the impact of soy‐based versus composite lipid emulsion on clinical outcomes of combined infections and liver dysfunction.
Volume
46
First Page
S100
Last Page
S101
Recommended Citation
Kless S, Zimmernan LH, Kroneman O. Impact of soy‐based versus composite lipid emulsion (soybean, medium chain triglycerides, olive and fish oil) in critically ill patients. Journal of Parenteral and Enteral Nutrition (JPEN) 2022;46:S100-S101. doi: 10.1002/jpen.2345
DOI
10.1002/jpen.2345